ADC Therapeutics 13G Filing Revealed on April 6: Form 13G for ADC Therapeutics was filed April 6, 2026; SEC Rule 13d-1 sets a 5% disclosure threshold. Investors should verify shares, filer identity and monitor… 👈 Read full analysis #ADCTherapeutics #SECfilings #biotech #investors #financialnews
0
0
0
0